Simvastatin
Product Images NDC 10544-486

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 10544-486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg 30ct (Label Simvastatin Tabs 20mg Bpi(10544 486 30) Zydus(68382 067 10) Rev1)

Simvastatin Tablets, USP 20mg bottle label from Blenheim Pharmacal, Inc. The label indicates a package containing 30 tablets. It includes dosage instructions to see package insert and storage conditions at controlled room temperature (20-25°C). Manufacturer and lot details are printed, along with barcode and regulatory information.*

FDA Label Image

40mg 30ct (Label Simvastatin Tabs 40mg Bpi(10544 487 30) Zydus(68382 068 10) Rev1)

Simvastatin Tablets, USP 40 mg bottle label by Blenheim Pharmacal, Inc. The label states the package contains 30 tablets for prescription use only. Storage instructions specify controlled room temperature and keeping out of reach of children. The label includes NDC 10544-487-30, manufacturer code 68382-068-10, and space for lot and expiration date information. The label also features a barcode and regulatory data.*

FDA Label Image

Structure (Simvastatinplr Figure 01)

Chemical structure diagram of the active ingredient Simvastatin, showing its molecular arrangement with rings, functional groups, and bonds as depicted in the image.*

FDA Label Image

Figure 1 (Simvastatinplr Figure 02)

A forest plot chart showing risk ratios with 95% confidence intervals for major vascular and major coronary events categorized by baseline characteristics such as diabetes status, peripheral vascular disease, cerebrovascular disease, gender, age, LDL-cholesterol, and HDL-cholesterol levels. The chart compares incidence rates (%) between treatment and placebo groups, indicating which group has a favored outcome.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.